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Introduction
Colon cancer is a major public health issue in the United States, with approximately 137,000 new cases and 50,000 deaths per year [1] . The increasing worldwide incidence of colon cancer has been linked to obesity and consumption of a high-fat (HF) Western diet [2] [3] [4] . Metaanalyses indicate that total energy intake is associated with a higher risk of colon cancer [5, 6] . The prevalence of obesity has increased drastically in the Western world as well as the regions where obesity was previously thought to be uncommon (e.g., China, South Korea) during recent decades [3] [4] [5] [6] . This global obesity epidemic has, in part, been attributed to the adoption of Western lifestyle, including increased consumption of a high-energy diet such as the high-fat diet (HFD) [5] [6] [7] .
There is strong epidemiologic evidence linking diet-induced obesity with increased risk of colon cancer [5] [6] [7] [8] . Mechanistically, consumption of an HFD can lead to accumulation of excess body fat that is associated with adipose tissue dysfunction and a chronic state of low-grade inflammation known to promote tumor development [9, 10] . Studies in which germ-free mice inoculated with stool from tumor-bearing mice developed more tumors than those inoculated with stool from tumor-free mice support a causal role for the gut microbiota in colon carcinogenesis in an azoxymethane (AOM)-induced colon cancer model [11] . A link between the gut microbiome and colon cancer is increasingly apparent, and an altered microbiota is found among individuals with colon cancer [12, 13] . For example, the Clostridium, Roseburia and Eubacterium spp. are less prevalent in colon cancer subjects than in healthy individuals [14] . In addition, some strains of Bacteroides fragilis and Escherichia coli are enterotoxigenic and directly promote tumorigenesis [11, 15] .
The symbiotic relationship of hundreds of microbial species with the host requires a tuned response to prevent host damage, e.g., inflammation, while supporting the presence of the potentially beneficial microbes. The colonic microbiota is critical for mucosal tolerance under normal conditions and prevents pathogen infections [16, 17] . Recent studies show that immunological processes participate in the maintenance of homeostasis with the microbiota and that disturbance of host immunity or the microbial ecosystem results in disease-provoking dysbiosis [16, 17] . The gastrointestinal tract is poised in a state of equilibrium that permits rapid protective responses against pathogens, but curtails damage by hindering long-lasting vigorous inflammatory processes [18] . While the pathways active in promoting obesity-related colon cancer remain to be characterized, it is possible that the process may involve the colonic microbiota, which affects gut inflammatory status and the extraction of energy from the diet [19] [20] [21] . It is known that dietary fiber type, fat composition, composition of gut microbiome/metabolites, animal species and experimental time point are the major factors contributing to the development of inflammation and colon cancer. However, there are few comprehensive studies including all above factors in the context of HFD-induced obesity. It remains largely unknown how colonic aberrant crypt (AC, putative preneoplastic lesions) formation affects gut microbiome/metabolite composition.
We hypothesize that not only does an HFD promote AC formation but obesity and AC formation are associated with bacterial dysbiosis in the colon. With a comprehensive manner, we tested this hypothesis using the HFD-induced obesity in an AOM mouse model.
Materials and methods

Animals, diets, AOM treatment and AC analysis
This study was approved by the Animal Care and Use Committee of the Grand Forks Human Nutrition Research Center (GFHNRC), and animals were maintained in accordance with NIH guidelines for the care and use of laboratory animals. Male C57BL/6 mice, 4 weeks old, were obtained from Harlan (Madison, WI, USA). Mice were individually housed in Plexiglas ventilated cages within a pathogen-free facility that maintained a 12-h light/dark cycle. Mice were given free access to food and deionized water and were allowed to acclimate in the facility for 2 days before being randomly assigned to two dietary treatment groups for 14 weeks. A modified AIN93G formulation [22] providing 16% (AIN, as a control) or 45% (HFD) of energy from corn oil was prepared by the GFHNRC (Table 1) [23, 24] . C57BL/6 mice were fed either an AIN or HFD (n=25/ group). On week 3, within a given diet group, mice received either weekly intraperitoneal injection of the colon carcinogen AOM (Sigma, St. Louis, MO, USA) (n=15/group) at a concentration of 8 mg/kg body weight [25] or phosphate-buffered saline (PBS, pH=7.4) carrier solution (n=10/group) for 4 weeks. Body weight was recorded weekly, and body composition was measured by magnetic resonance imaging (EchoMRI, Houston, TX, USA) at week 2 and week 14. At the termination of the experiment, mice were fasted for 6 h and then euthanized with a mixture of ketamine and xylazine (100 mg/kg body weight). Plasma samples were collected and stored at − 80°C for analyses of leptin, interleukin-6 (IL6), tumor necrosis factor-alpha (TNFα), Creactive protein (CRP), monocyte chemoattractant protein-1 (MCP1) and lipopolysaccharide (LPS).
AC and AC foci (ACF) were determined as previously described [26] . Briefly, the entire colon segment and rectum were flushed with PBS solution. Subsequently, the colon and rectum were cut open along the longitudinal median axis and fixed flat on a microscope slide. The fixed colon segments were stained with 0.05% methylene blue. With methylene blue staining, AC was larger and had a thicker blue lining of epithelial cells than normal crypt; ACF was a darker blue cluster containing one or several ACs. The total number of AC and ACF was scored in a blinded manner by using a dissecting microscope to visualize AC/ACF in the entire colon segment which includes ascending, transverse and descending regions.
Plasma leptin, IL6, TNFα, CRP, MCP-1 and LPS
The leptin, IL6, TNFα and MCP-1 concentrations were measured in plasma using enzyme-linked immunosorbent assay kits (R&D Systems, Inc., Minneapolis, MN, USA). Plasma CRP and LPS were assessed by using a CRP (Mouse) assay kit (ANPCO Diagnostics, Salem, NH, USA) and LAL Endotoxin detection Kit (GenScript USA Inc., Piscataway, NJ, USA).
Ileum histology, iNOS and Ki67 immunohistochemistry
Because the colon segment (after AC/ACF analysis) was not suitable for the study of histological end points, we then chose the end region of the ileum segment (a region immediately upstream of the colon). Ileum segments were fixed in 10% neutral buffered formalin and embedded in paraffin. Five-micrometer sections were mounted on slides and stained with hematoxylin and eosin. Rabbit polyclonal iNOS (cat. #Ab15323) and Ki67 (cat. #Ab16667) antibodies (Abcam Inc., Cambridge, MA, USA) were diluted 1:100. The iNOS and Ki67 protein levels were assessed using an immunohistochemistry detection kit including a biotinylated goat anti-rabbit antibody (cat. #Ab64261) with 1:200 dilution (Abcam Inc., Cambridge, MA, USA). Each ileum section was scored for the area of infiltration of inflammatory cells, iNOS, Ki67 and their respective total section area (μm 2 ) using a standardized determination of morphology [27, 28] . The target areas were captured using a Nikon Ci-L Microscope and Leica DFC420 C digital camera. Image Pro Plus Version 9.1 software (Media Cybernetics, Inc., Rockville, MD, USA) was used for quantification of digitized images.
Western blot analysis of the expression of cytochrome P450 2 E1 (CYP2E1) in the liver
Cell lysates were made by sonicating homogenized liver tissues at 4°C using a tissue lysis buffer (Cell Signaling Technologies, Inc., Danvers, MA, USA) as previously described [29] . The protein concentration was quantified by the Bradford dye-binding assay (BioRad Laboratories, Hercules, CA, USA). Equal amounts of protein extract (40 μg) samples were resolved over 4%-20% Tris-glycine gradient gels under denaturing and reducing conditions and electroblotted onto polyvinylidene fluoride membranes (Invitrogen, Carlsbad, CA, USA). Membrane blots were blocked in PBS containing 0.05% Tween (v:v) supplemented with 1% (wt:v) nonfat dry milk (BioRad, Hercules, CA, USA) at 4°C for overnight. Membranes were probed with antibodies (1:3000 dilution) against CYP2E1 (cat. #28146) (Abcam, Inc., Cambridge, MA, USA) and then incubated with an antirabbit (1:5000 dilution) HRP-conjugated secondary antibody (cat. #7074) (Cell Signaling Technology, Inc., Danvers, MA, USA) in blocking solution for 1 h at room temperature. Blots were washed as above, and proteins were detected by using an enzymatic chemiluminescence plus kit (Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA) with the Molecular Dynamics Image-Quant system (Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA).
Detection and quantitation of bacterial composition in fecal samples and 16S sequencing
Fecal pellets were collected from each mouse prior to sacrifice at the end of the study and stored at −80°C. DNA was extracted from mouse fecal samples using a QIAamp DNA stool Mini Kit (Qiagen, Valencia, CA, USA). DNA was quantified using a Nanodrop Spectrophotometer. The 16S universal Eubacterial primers 341F CCTACGGGNGGCWGCAG and 785R GACTACHVGGGTATCTAATCC were utilized to generate amplicon products from different samples. A single-step 30-cycle PCR using HotStarTaq Plus Master Mix Kit (Qiagen, Valencia, CA) was used under the following conditions: 94°C for 3 min, followed by 28 cycles of 94°C for 30 s; 53°C for 40 s and 72°C for 1 min; after which a final elongation step at 72°C for 5 min was performed [30] . Following polymerase chain reaction (PCR), all amplicon products from different samples were mixed in equal concentrations and purified using Agencourt Ampure beads (Agencourt Bioscience Corporation, Beverly, MA, USA), and samples were sequenced in Molecular Research LP using Illumina MiSeq chemistry platform. Sequencing data are provided through NCBI under BioProject accession #PRJNA351257. 
Fecal short-chain fatty acid (SCFA) analysis
Fecal pellets were collected from each mouse prior to sacrifice at the end of the study and stored at −80°C. Pulverized mouse fecal samples (25 mg) were suspended in 1 ml water, acidified with 54 μl 6 M HCl and spiked with ethyl-butyric acid as an internal standard in the analyzed solution (0.26 mmol/L). Samples were homogenized by a TissueLyser (Qiagen, Valencia, CA, USA) and then kept on ice for 15 min with intermittent vortexing. The samples were centrifuged at 17,000×g for 20 min at 4°C, and the supernatant was collected. The SCFA composition was measured by gas chromatography using a Thermo Trace-1310 equipped with a TriPlus RSH Autosampler (Thermo Fisher, Waltham, MA, USA) and a fatty acid phase column (DB-FFAP 125-3237, J&W Scientific, Agilent Technologies Inc., Santa Clara, CA, USA) as previously described [31] .
Statistical analysis
Results are given as mean ± standard deviation (S.D.). The effects of diet (AIN or HFD) and AOM treatment (with or without) on mouse body weight, body composition, inflammatory cytokines and immunohistochemistry variables were analyzed using a two-way analysis of variance and Tukey's contrasts for post hoc comparisons. JMP V12 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses. To analyze the DNA sequencing data and various microbiome measures, statistical analysis was performed using a variety of computer packages including the open-source computer software QIIME/MOTHUR ver. 1.38 program (SAS Institute Inc., Cary, NC, USA) [32, 33] . The number of operational taxonomic units (OTUs) and weighted UniFrac distance matrices were used to evaluate the number of species (alpha diversity) and bacterial community structure in different groups, respectively. These diversity analyses were conducted as previously described [30, [34] [35] [36] using QIIME (www.qiime.org). The significance of microbial percentage abundance between groups, defined as having a threshold N0.28% in at least one treatment group, was determined by XLstat NCSS 2010 and R language using multivariate analysis of variance coupled with Tukey's honestly significant difference to adjust P values. A correlogram was created in R (corrplot language) using Pearson rank correlations of abundance data for Anaeroplamsa and Lactobacillus at the genus and individual species levels. Differences with a P value b.05 were considered statistically significant.
Results
Effects of the HFD and AOM treatment on daily food consumption, body mass and body fat composition
The average daily food intakes in the AIN and AIN-AOM groups were greater (Pb.05) than that of the HFD and HFD-AOM groups (3.93±0.14 g, 3.95±0.16 g vs 3.30±0.15 g, 3.28±0.19 g), respectively. However, the energy intakes (calories/day) in the AIN and AIN-AOM, HFD and HFD-AOM groups did not differ (15.85±0.58, 15.93±0.65, 15.94±0.72, 15.84±0.0.93), respectively. The AOM treatment did not change the food intake within a given diet. The HFD consumption increased body mass when compared to AIN groups 3 weeks after initiation of experimental feeding (Fig. 1A) . Although the AOM treatment decreased the rate of body mass weight gain compared to the respective untreated groups, the AIN-AOM and HFD-AOM groups experienced body mass weight gain over the entire experiment (Fig. 1A) . Regardless of the AOM treatment, the HFD group increased the percent body fat mass by 0.32-fold compared with the AIN group (Fig. 1B) ; however, the absolute lean mass weight in the HFD group was greater than in the HFD-AOM, AIN and AIN-AOM groups at the end of experiment (Fig. 1C) . . At a given time, if two bars share at least one letter, then the difference between them is not statistically significant. However, if they do not have a letter in common, then the difference between them is statistically significant, Pb.05. 
Effects of the HFD and AOM treatment on plasma inflammatory cytokines and LPS
The concentrations of plasma leptin in the HFD and HFD-AOM group were 1.45-and 1.77-fold greater than in the AIN and AIN-AOM groups, respectively. Furthermore, the concentrations of plasma TNFα, IL 6 and MCP-1 were at least 1-fold greater in the HFD-AOM group than in the AIN, AIN-AOM and HFD groups; similarly, the concentration of plasma LPS was 0.5-fold greater in the HFD-AOM group than in the AIN group. However, the concentrations of plasma CRP did not differ between groups (Table 2) . 
Effects of the HFD and AOM treatment on inflammatory cell infiltration, iNOS and Ki67 protein level in ileum
At the end of the experiment, histological examination of ileum sections showed that the areas of inflammatory cells in the HFD and HFD-AOM groups were 1.64-to 1.72-fold greater than in the AIN and AIN-AOM groups (Fig. 2A) . The level of the proinflammatory cytokine regulator iNOS protein in the HFD-AOM group was 0.41-, 0.22-and 0.25-fold greater than in the AIN, AIN-AOM, HFD groups (Fig. 2B) , respectively. The level of cell proliferation marker Ki67 protein in the HFD-AOM groups was 1.12-and 0.76-fold greater than in the AIN and AIN-AOM groups (Fig. 2C) , respectively.
Effects of the HFD on AC/ACF formation
The number of AC and ACF in the HFD-AOM group was 0.80-and 0.81-fold greater than in the AIN-AOM group, respectively. The AIN and HFD groups did not develop AC and ACF (Fig. 3A and B) .
Effects of the HFD and AOM treatment on hepatic P450 2E1 protein level
The levels of hepatic CYP2E1protein, the major AOM bioactivation enzyme [37] , did not differ in the AIN, AIN-AOM, HFD and HFD-AOM groups (Fig. 4) .
Effects of the HFD on gut microbial diversity and composition
The OTUs at the species level and the Shannon diversity index were used to determine the diversity of bacterial species within a treatment group. Although the AIN and HFD groups did not differ, the HFD-AOM group had a higher bacterial diversity when compared to that of AIN-AOM group (Table 3 ). In contrast, there was a significant difference in the bacterial community structure based on diet but not AOM treatment (Fig. 5) . At the phylum level, the HFD-AOM group increased the abundance of Proteobacteria but decreased the abundance of Actinobacteria when compared with the AIN-AOM group. Similarly, the HFD-AOM group had higher abundance of Tenericutes bacteria than in the HFD group (Fig. 6) . With an abundance threshold of N0.28% total bacteria in at least one experimental group, we identified significant changes in 21 genera, 10 families, 4 orders, 4 classes and 3 phyla due to differences in diet, AOM treatments or both (Fig. 6 , Tables  3 and 4) . At genus level, three major (high abundance) bacterial taxa (Bacteroides, Barnesiella, Lachnoclostridium), which are responsible for SCFA production [38] [39] [40] [41] , were at least 1-fold higher in the AIN group when compared with the HFD group (Table 3) . We also found that the abundance of Anaeroplasma (an opportunistic pathogen) and Values are means ± S.D., n=8/group. If two values share at least one letter, then the difference between them is not statistically significant. However, if they do not have a letter in common, then the difference between them is statistically significant, Pb.05. Lactobacillus bacteria increased 6.6-and 18.1-fold, respectively, in the HFD-AOM group when compared with the HFD group (Table 3) . Moreover, the analysis indicated that there was a positive relationship of AC/ACF number and the abundance of Anaeroplasma/Lactobacillus bacteria at genus and species levels (Fig. 7) .
Effects of the HFD on fecal SCFA content
As we detected a higher abundance of SCFA-producing bacteria in the AIN group when compared with the HFD group, we then determined fecal SCFA content. Due to AOM treatment, the amount of fecal acetic acid was decreased by 30% in the HFD-AOM group when compared with the AIN and AIN-AOM groups. However, the content of propionic acid and butyric acid did not differ (Fig. 8) .
Discussion
Epidemiological and experimental data suggest that obesity increases colon cancer risk [ 2,3,6-9 ]. In the current study, we tested the hypothesis that obesity promotes AC formation with an increase of pathogenic bacteria in the colon using an HFD to produce outcomes similar to those observed adiposity in humans [9, 42, 43] . Our data support this hypothesis and demonstrate involvement of inflammatory processes and changes in the microbiome.
The HFD consumption induces obesity
It is interesting to note that the daily calorie intake did not differ but the HFD group exhibited a significant increase in body weight and fat mass percentage when compared with the AIN group (Fig. 1) . This observation is likely due to the nutrient utilization and energy expenditure because laboratory rodents fed energy-rich HF diets (ad lib) exhibit particularly deleterious effects on circadian rhythm, leading to the disruption of metabolic cycle [44, 45] . Second, an HFDinduced obesity is mainly due to the fat mass increase; fat as energy source requires fewer biochemical steps to produce the fat mass when compared with that of protein/carbohydrate as energy [44, 45] . Third, the germ-free animal studies have shown that the development of a microbiome favored by an HFD promotes energy harvest and storagepromoting obesity and metabolic diseases [46, 47] . 
The combination of HFD consumption and AOM treatment greatly increases inflammatory responses
The cytokines serve as messengers between cells and regulate various inflammatory responses. Leptin, TNF-α, IL6 and MCP-1 are key obesity-related proinflammatory cytokines [9, 48] . They are released by inflammatory cells infiltrating adipose tissue and regulate cell survival, apoptosis, migration and macrophage infiltration into adipose tissue [49, 50] . These proinflammatory cytokines were greatly elevated in the HFD-AOM group compared with other groups (Table 2) .
Similarly, we examined the gut inflammation using ileum segment because the entire colon segment was used to determine AC/ACF number. First, in the normal ileum segment, few inflammatory cells can be found in the mucosa next to the basal membrane of the epithelial layer, but at the inflamed tissue, the inflammatory cells are greatly increased in the lamina propria of intestine, and these cells secret proinflammatory cytokines and other related mediators [51, 52] . In our study, HF feeding caused an increase of inflammatory cells in ileum segments (Fig. 2A) , suggesting that ileum was more inflamed in the HFD and HFD-AOM groups than the AIN and AIN-AOM groups. Second, the regulation of proinflammatory cytokines by iNOS may contribute to the pathogenesis of the inflammatory process, and the expression of iNOS was significantly increased in inflamed tissue [53, 54] . Similarly, intestinal inflammation is invariably associated with increased epithelial proliferation. However, in the intestine, it is more difficult to examine changes in cell proliferation, but using cell proliferation gene Ki67, epithelial proliferation has been shown to be increased in inflamed tissue [55, 56] . Moreover, nitric oxide generated at the inflammatory site contributes to the initiation and progression of colon tumorigenesis by enhancing expression of proinflammatory enzyme iNOS and cell proliferation gene Ki67 [57, 58] . Therefore, the hindgut region was more inflamed in the HFD-AOM group than the other groups ( Fig. 2B and C) because the region of the ileum we used was located at the immediate upstream of an ascending colon, and it shares the similar inflammatory status with the colon segment. Indeed, we have previously demonstrated that the ileum and colon segments yield similar results on inflammatory cell filtration, iNOS and Ki67 protein levels in response to low-and high-fat diet treatment [59] . Our observation is also consistent with the report that the colonic stem cells of the HF-fed mice exhibited statistically significant increases in cell proliferation and decreases in apoptosis in response to AOM injection compared to the control group [60] . Future studies on the effects of HF feeding on colonic stem cell maintenance, proliferation and molecular signals in a primary organoid model from the AIN-or HFD-fed mice may provide insight into the mechanistic pathways directly related to colonic AC formation [60, 61] .
Overall, that both the HFD and AOM stimuli were needed suggests synergistic or complementary effects on increasing proinflammatory cytokines and gut inflammation. Table 2 ). This observation suggests a critical role of HFD and inflammation in promoting colonic AC/ACF formation. Likewise, the colonic AC/ACF formation could also exacerbate inflammation status, which may become a vicious cycle between colonic AC/ACF formation and chronic inflammatory responses in the HFD-AOM group.
Data suggest that N-nitrosodimethylamine, an AOM isomer, in processed red meat is a major risk factor for colon cancer [62] . In addition, humans are exposed to structurally related hydrazine derivatives found in mushrooms, tobacco, herbicides, rocket fuels and drugs [63] . In contrast to genetically engineered mouse models, AOM induces tumors preferentially in the mouse distal colon with pathological features known to be associated with human sporadic colorectal cancer [64] . Furthermore, a meta-analysis indicated that AOM rodent models were better than genetically engineered models of carcinogenesis in predicting efficacy in humans [64] . As previous data suggest that certain extremely HF feeding conditions (e.g., 60% fat vs 10% fat as energy source) increase the expression of CYP2E1enzyme which metabolizes AOM in the liver to the bioactive carcinogen [25] . These bioactive metabolites of CYP2E1 are transported to the colon via the bloodstream [37] . However, the contributions of the liver to AOM-induced DNA damage and AC formation in the colon have not been directly determined [65] . In our present study, the moderate HF feeding (e.g., 45% fat (HFD) vs 16% fat (AIN) as energy source) did not increase CYP2E1 enzymes but did enhance AC/ACF formation (Fig. 4) . Thus, our data support the recent report showing that colonic AC/ACF formation is critically dependent on AOM bioactivation by gut bacteria but not hepatic CYP2E1 enzymes [65] . Although there are studies on HFD and gut microbiota [66, 67] , much remains to be determined in the connection of HFD and AC/ACF formation, gut inflammation and microbiota in a mouse model. To gain further insight into the relationship of colon pathophysiology and microbiota, we characterized the HFD-enhanced AC/ACF formation and the respective gut microbiome composition. We found that alpha diversity of the gut microbiome in the AIN and HFD groups did not differ but the HFD-AOM group had a higher diversity which might include pathogenic bacteria when compared to the AIN-AOM group. This observation may reflect the adaptive response that the AIN and HFD groups experience under the different stress conditions (e.g., higher AC number in the HFD-AOM group) due to AOM treatment (Table 3) . However, the overall bacterial community structure, beta diversity, was mainly determined by diet (e.g., AIN and HFD) but not AOM treatment or AC formation (Figs. 3, 5) .
Similarly, the bacterial abundance at the phylum level in the AIN and HFD groups did not differ. However, the HFD-AOM group increased Proteobacteria but decreased Actinobacteria bacterial abundance when compared to the AIN-AOM group (Figs. 6) . The high abundance of Proteobacteria, a microbial signature of dysbiosis, in the HFD-AOM group suggests the unhealthy gut microbiota during AOMinduced AC formation [68, 69] .
At the genus level, AOM administration increased the abundances of Anaeroplasma bacteria (belonging to Mollicutes class, Tenericutes phylum) and Lactobacillus bacteria, especially in those mice fed an HFD (Figs. 6 and 7; Tables 3 and 4 ). However, the elevated level of AC/ ACF in the HFD-AOM group did not significantly associate with the abundance of Anaeroplasma and Lactobacillus bacteria when compared to the AIN-AOM group (Figs. 3, 6 and 7 ; Table 3 ). This observation suggests that AC/ACF formation (AOM treatment) specifically associates with an increase of Anaeroplasma bacteria, and an HFD may promote this association. The Anaeroplasma bacteria are negative by Gram stain, and they are parasites/opportunistic pathogens which elicit various host immune responses in numerous human diseases including colon cancer [70, 71] . The important role of LPS in Gramnegative bacteria-induced inflammation has been widely recognized because LPS causes monocytes and phagocytic cells to produce inflammatory cytokines [72, 73] . Consistent with these data, there was also a high level of plasma LPS (Table 2) in the HFD/AOM group. Therefore, it is conceivable that the increase of Anaeroplasma bacteria and LPS in the HFD/AOM group may, at least, trigger gut inflammation and circulating inflammatory cytokines ( Fig. 2 ; Table 2 ). On the other hand, Lactobacillus bacteria are generally considered to be probiotic and bile acid tolerant and exhibit beneficial properties relevant to human health (e.g., bile acid deconjugation, anti-infective/anticancer) [74, 75] . The concomitant increases in the abundance of both Anaeroplasma and Lactobacillus taxa with opposing health impacts (Fig. 7) are likely the result of host-symbiont interactions in which the host requires a tuned response that prevents further host damage (e.g., ACF formation, pathogen infection). This symbiotic relationship might have been established during microbe-host coevolution.
One of the health effects attributed to the production of SCFA is to inhibit pathogenic microorganisms and to maintain the gut barrier function [38] . Although the abundance of certain SCFA-producing bacteria (e.g., Barnesiella,) [38] [39] [40] [41] was lower in the HFD and HFD-AOM groups, of the fecal SCFA measured, only acetic acid was lower in the HFD-AOM group compared with the AIN and AIN-AOM groups (Table 3 ; Fig. 8 ). This observation was initially counterintuitive given the report that HFD-induced obesity reduces butyrate level in the colon [76] . However, further studies show that there are no consistent conclusions in this regard [76, 77] . For example, it did not reduce the concentration of fecal SCFAs in obese mice fed an HFD with 60% calories from fat [77] , while the other study showed that an HFD reduced the butyrate level when (only) pectin was used as fiber source at the initial experimental time point [76] . Therefore, the fiber type (e.g., pectin) and microbial adaptation time point are two critical factors in detecting the reduction of butyrate level in HFD-induced obese mice [76, 77] . Similarly, the fecal SCFA concentration did not differ between the AIN and HFD groups, although SCFA-producing bacteria (Bacteroides, Barnesiella, Lachnoclostridium) were in high abundance in the AIN group in our study. This is likely due to the fact that cellulose (an insoluble fiber) was used in our experiments (14 weeks). Our other finding suggests that while the HFD determined the abundance of SCFA-producing bacteria, the combination of HF feeding and AOM treatment was required to decrease fecal acetic acid content. The decrease of acetic acid content in the HFD-AOM group may, at least, be partially related to the dysbiosis because acetic, propionic, butyric acids or their mixture can improve the profile of gut microbiota in the HFD-fed mice [77] . These data also suggest that fecal acetic acid content is more sensitive to the effect of combining dietary fat change and colonic AC formation when compared with other SCFA species.
Concluding remarks
Our data showed that the HFD promoted colonic AC/ACF formation concurrent with an increase of opportunistic pathogenic bacteria and a decrease of SCFA-producing bacteria. Consistent with above observation, AC/ACF formation also associated with an increase of circulating LPS and proinflammatory cytokines, and a decrease of fecal acetic acid. The present study represents a comprehensive report in which we simultaneously determined the impact of the HFD on gut inflammation, colonic ACF formation, gut microbiome composition and their metabolites. Although future human studies are needed when extrapolating these data in clinical application, our newly identified microbiome signatures (e.g., Anaeroplasma) in this study may open new avenues for seeking noninvasive biomarkers.
